Therapy-resistent lupus skin disease successfully treated with rituximab

被引:13
作者
Risselada, A. P. [1 ]
Kallenberg, C. G. M. [1 ]
机构
[1] Univ Groningen, Med Ctr, Dept Rheumatol & Clin Immunol, NL-9700 RB Groningen, Netherlands
关键词
D O I
10.1093/rheumatology/kel162
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:915 / 916
页数:3
相关论文
共 10 条
[1]   Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus [J].
Arin, MJ ;
Engert, A ;
Krieg, T ;
Hunzelmann, N .
BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (03) :620-625
[2]   Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens [J].
Cuadrado, MJ ;
Karim, Y ;
Sanna, G ;
Smith, E ;
Khamashta, MA ;
Hughes, GRV .
AMERICAN JOURNAL OF MEDICINE, 2005, 118 (03) :246-250
[3]   Cutaneous lupus erythematosus - Diagnosis and management [J].
Fabbri, P ;
Cardinali, C ;
Giomi, B ;
Caproni, M .
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2003, 4 (07) :449-465
[4]   Successful treatment of refractory childhood pemphgus vulgaris with anti-CD20 monoclonal antibody (Rituximab) [J].
Kong, HH ;
Prose, NS ;
Ware, RE ;
Hall, RP .
PEDIATRIC DERMATOLOGY, 2005, 22 (05) :461-464
[5]   B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients [J].
Leandro, MJ ;
Cambridge, G ;
Edwards, JC ;
Ehrenstein, MR ;
Isenberg, DA .
RHEUMATOLOGY, 2005, 44 (12) :1542-1545
[6]   B cell depletion as a novel treatment for systemic lupus erythematosus - A phase I/II dose-escalation trial of rituximab [J].
Looney, RJ ;
Anolik, JH ;
Campbell, D ;
Felgar, RE ;
Young, F ;
Arend, LJ ;
Sloand, JA ;
Rosenblatt, J ;
Sanz, I .
ARTHRITIS AND RHEUMATISM, 2004, 50 (08) :2580-2589
[7]   Cutaneous lupus erythematosus: a review [J].
Patel, P ;
Werth, V .
DERMATOLOGIC CLINICS, 2002, 20 (03) :373-+
[8]   Rituximab therapy and autoimmune disorders - Prospects for anti-B cell therapy [J].
Silverman, GJ ;
Weisman, S .
ARTHRITIS AND RHEUMATISM, 2003, 48 (06) :1484-1492
[9]   Successful long-term treatment of systemic lupus erythematosus with rituximab maintenance therapy [J].
Weide, R ;
Heymanns, J ;
Pandorf, A ;
Köppler, H .
LUPUS, 2003, 12 (10) :779-782
[10]   Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus:: results of a retrospective study in 43 patients [J].
Wenzel, J ;
Brähler, S ;
Bauer, R ;
Bieber, T ;
Tüting, T .
BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (01) :157-162